‘Nog vroeg om winst te nemen op Amgen’ 27 Aug 2013 | 11:54 am

Amgen-belegger in zevende hemel na overname Onyx 27 Aug 2013 | 11:52 am

5 favoriete aandelen van Geert Vastiau 26 Aug 2013 | 12:04 pm

De aandelen van de week 26 Aug 2013 | 12:02 pm

Belgisch kattenmedicijn charmeert Novartis 26 Aug 2013 | 12:00 pm

Bel20 beëindigt drie dagen durende verliesreeks - MDxHealth en Ablynx op de beurs 23 Aug 2013 | 11:37 am

Okapi Sciences enters into a license agreement 23 Aug 2013 | 11:25 am

Okapi Sciences NV (‘Okapi Sciences’), a biopharmaceutical company focused on developing innovative antiviral treatments for animals, announces today that it has entered into an exclusive agreement wit...

Bel20 kleurt voor de derde dag op rij rood - TiGenix en Genzyme op de beurs 22 Aug 2013 | 01:50 pm

MDxHealth Reports 2013 First-Half Results 22 Aug 2013 | 11:12 am

MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the diagnosis and treatment of cancer patients, today announced ...

Appointment of Catherine Moukheibir to Board of Ablynx 21 Aug 2013 | 03:42 pm

The meeting of the Board of Directors on 20th August approved the appointment of Catherine Moukheibir as an Independent Director of the Company.